We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TeGenero Trial Adverse Events Raise Safety, Consent Issues
The highly publicized health problems suffered by several participants in TeGenero’s UK-based clinical trial for TGN1412, an immune-boosting drug, have raised new questions about patient protection and informed consent issues in trials.